Patients dropped fewer pounds during real-world use compared to the amount lost in clinical trials Getty A new study analyzed patients who used GLP-1 medications in a real-world setting Researchers ...
A new study shows that a third of American teenagers prefer chatting with artificial intelligence companions over having real friends. Common Sense Media’s report, titled "Talk, Trust, and Trade-Offs: ...
The mode, free for all almost all logged-in users, provides hints and self-reflection prompts to encourage students to get to the solution themselves. OpenAI has introduced a new Study Mode for ...
Generative artificial intelligence is everywhere, but not everyone is ready to embrace it — and it’s not just people who fear that AI might replace their jobs or that ChatGPT will become sentient and ...
A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight loss in a real-world setting because patients discontinue treatment or use ...
Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised by the drugs' clinical trials, a new study says. People taking such GLP-1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results